Abstract
Ligation of the Fas cell surface receptor leads to activation of caspases and subsequent apoptosis. Members of the Bcl-2 family of proteins control the cellular commitment to apoptosis, although their role in Fas-induced apoptosis is ill-defined. In this report we demonstrate that the pro-apoptotic protein, Bax, translocates from the cytosol specifically to the mitochondria following Fas ligation in MCF10A1 breast epithelial cells. Bax translocation was dependent on caspase activation, and preceded the release of cytochrome c and loss of mitochondrial respiratory activity. Bax translocation occurred in concert with activation of downstream caspases as determined by cleavage of a synthetic substrate, proteolysis of poly(ADP-ribose) polymerase, and processing of procaspase-3 and -7. Overexpression of the anti-apoptotic protein, Bcl-2, prevented Bax insertion, cytochrome c release, complete processing of caspase-3 and -7, and full activation of DEVD-specific cleavage activity. These data establish a role for Bax mitochondrial insertion during Fas-mediated apoptosis, and support a model in which Bax insertion amplifies the Fas apoptotic cascade through cytochrome c release and complete processing of caspases-3 and -7. In addition, our findings indicate that prevention of Bax insertion into the mitochondria represents a novel mechanism by which Bcl-2 inhibits Fas-induced apoptosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adachi S, Cross AR, Babior BM and Gottlieb RA. . 1997 J. Biol. Chem. 272: 21878–21882.
Adams JM and Cory S. . 1998 Science 281: 1322–1326.
Boise LH and Thompson CB. . 1997 Proc. Natl. Acad. Sci. USA 94: 3759–3764.
Boldin MP, Goncharov TM, Goltsev YV and Wallach D. . 1996 Cell 85: 803–815.
Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH and Wallach D. . 1995 J. Biol. Chem. 270: 7795–7798.
Chao DT and Korsmeyer SJ. . 1998 Ann. Rev. Immunol. 16: 395–419.
Chinnaiyan AM, O'Rourke K, Tewari M and Dixit VM. . 1995 Cell 81: 505–512.
Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME and Dixit VM. . 1996 J. Biol. Chem. 271: 4961–4965.
Cohen GM. . 1997 Biochem. J. 326: 1–16.
Cory S and Adams JM. . 1998 Biochim. Biophys. Acta 1377: R25–R44.
Enari M, Talanian RV, Wong WW and Nagata S. . 1996 Nature 380: 723–726.
Green DR and Reed JC. . 1998 Science 281: 1309–1312.
Gross A, Jockel J, Wei MC and Korsmeyer SJ. . 1998 EMBO J. 17: 3878–3885.
Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM and Mak TW. . 1998 Cell 94: 339–352.
Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, Okazaki T, Yamamoto K and Sasada M. . 1998 J. Exp. Med. 187: 587–600.
Hsu Y-T, Wolter KG and Youle RJ. . 1997 Proc. Natl. Acad. Sci. USA 94: 3668–3672.
Hsu Y-T and Youle RJ. . 1998 J. Biol. Chem. 273: 10777–10783.
Janicke RU, Sprengart ML, Wati MR and Porter AG. . 1998 J. Biol. Chem. 273: 9357–9360.
Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D and Reed JC. . 1998 Proc. Natl. Acad. Sci. USA 95: 4997–5002.
Keane MM, Ettengerg SA, Lowrey GA, Russell EK and Lipkowitz S. . 1996 Cancer Res. 56: 4791–4798.
Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD. . 1997 Science 275: 1132–1136.
Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W and Reed JC. . 1993 Cancer Res. 53: 4701–4714.
Kuwana T, Smith JJ, Muzio M, Dixit V, Newmeyer DD and Kornbluth S. . 1998 J. Biol. Chem. 273: 16589–16594.
Li H, Zhu H, Xu C-j and Yuan J. . 1998 Cell 94: 491–501.
Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X. . 1997 Cell 91: 479–489.
Lock RB and Stribinskiene L. . 1996 Cancer Res. 56: 4006–4012.
Luo X, Budihardjo I, Zou H, Slaughter C and Wang X. . 1998 Cell 94: 481–490.
Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH and Peter ME. . 1997 EMBO J. 16: 2794–2804.
Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM. . 1996 Cell 85: 817–827.
Muzio M, Stockwell BR, Stennicke HR, Salvesen GS and Dixit VM. . 1998 J. Biol. Chem. 273: 2926–2930.
Nagata S and Golstein P. . 1995 Science 267: 1449–1456.
Reed JC. . 1997 Nature 387: 773–776.
Rosen A and Casciola-Rosen L. . 1997 J. Cell Biochem. 64: 50–54.
Rosse T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B and Borner C. . 1998 Nature 391: 496–499.
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin K-M, Krammer PH and Peter ME. . 1998 EMBO J. 17: 1675–1687.
Scaffidi C, Medema JP, Krammer PH and Peter ME. . 1997 J. Biol. Chem. 272: 26953–26958.
Shibasaki F, Kondo E, Akagi T and McKeon F. . 1997 Nature 386: 728–731.
Srinivasan A, Li F, Wong A, Kodandapani L, Smidt Jr R, Krebs JF, Fritz LC, Wu JC and Tomaselli KJ. . 1998 J. Biol. Chem. 273: 4523–4529.
Suda T, Takahashi T, Golstein P and Nagata S. . 1993 Cell 75: 1169–1178.
Susin SA, Zamzami N, Castedo M, Daugas E, Wang H-G, Geley S, Fassy F, Reed JC and Kroemer G. . 1997 J. Exp. Med. 186: 25–37.
Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M and Kroemer G. . 1996 J. Exp. Med. 184: 1331–1341.
Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D, Ghayur T, Brady KD and Wong WW. . 1997 J. Biol. Chem. 272: 9677–9682.
Thornberry NA and Lazebnik Y. . 1998 Science 281: 1312–1316.
Toyoshima F, Moriguchi T and Nishida E. . 1997 J. Cell Biol. 139: 1005–1015.
Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, Debatin K-M and Krammer PH. . 1989 Science 245: 301–305.
Wang Z-Q, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M and Wagner EF. . 1995 Genes Dev. 9: 509–520.
Wolter KG, Hsu Y-T, Smith CL, Nechushtan A, Xi X-G and Youle RJ. . 1997 J. Cell Biol. 139: 1281–1292.
Xiang J, Chao DT and Korsmeyer SJ. . 1996 Proc. Natl. Acad. Sci. USA 93: 14559–144563.
Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP and Wang X. . 1997 Science 275: 1129–1132.
Acknowledgements
The authors thank Dr Maria Kavallaris for technical assistance with the immunofluorescence and confocal microscopy. This work was supported by the Children's Cancer Institute Australia for Medical Research which is affiliated with the University of New South Wales and Sydney Children's Hospital. KM Murphy is supported in part by a grant from the DEPSCoR initiative in Kentucky to Uldis N Streips.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murphy, K., Streips, U. & Lock, R. Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2. Oncogene 18, 5991–5999 (1999). https://doi.org/10.1038/sj.onc.1203001
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203001
Keywords
This article is cited by
-
The pathological role of IL-18Rα in renal ischemia/reperfusion injury
Laboratory Investigation (2015)
-
The rheostat in the membrane: BCL-2 family proteins and apoptosis
Cell Death & Differentiation (2014)
-
MicroRNAs Regulate the Chaperone Network in Cerebral Ischemia
Translational Stroke Research (2013)
-
Hydroxysafflor Yellow A Protects Against Cerebral Ischemia–Reperfusion Injury by Anti-apoptotic Effect Through PI3K/Akt/GSK3β Pathway in Rat
Neurochemical Research (2013)
-
Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice
British Journal of Cancer (2004)